Biogen Inc.
BIIB
$147.37
$3.602.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.63B | 1.62B | 1.16B | 1.17B | 1.16B |
| Total Depreciation and Amortization | 673.20M | 629.30M | 571.50M | 530.00M | 494.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 725.30M | 714.20M | 804.80M | 641.80M | 540.00M |
| Change in Net Operating Assets | -155.20M | -831.60M | -751.00M | -693.30M | -648.70M |
| Cash from Operations | 2.88B | 2.13B | 1.78B | 1.65B | 1.55B |
| Capital Expenditure | -153.70M | -179.60M | -218.80M | -256.30M | -277.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.07B | -1.67B | -6.93B | -6.93B | -6.93B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 429.30M | 412.00M | 5.15B | 3.97B | 3.10B |
| Cash from Investing | -799.20M | -1.43B | -1.99B | -3.21B | -4.10B |
| Total Debt Issued | -- | 0.00 | 997.20M | 997.20M | 997.20M |
| Total Debt Repaid | -650.00M | -1.30B | -1.46B | -1.21B | -809.90M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -33.50M | -37.50M | -19.60M | -34.20M | -38.00M |
| Cash from Financing | -683.50M | -1.34B | -482.30M | -246.90M | 149.30M |
| Foreign Exchange rate Adjustments | -67.70M | 54.60M | -16.50M | -8.00M | 35.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.33B | -588.70M | -708.90M | -1.82B | -2.37B |
